查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
心臟生物标誌物全球市场研究报告——2023-2030 年行业分析、规模、份额、增长、趋势和预测
市场调查报告书
商品编码
1264210

心臟生物标誌物全球市场研究报告——2023-2030 年行业分析、规模、份额、增长、趋势和预测

Global Cardiac Biomarkers Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 167 Pages | 商品交期: 最快1-2个工作天内

价格

全球对心臟生物标誌物的需求预计将从 2022 年的 182 亿美元增长到 2030 年的约 675.8 亿美元，2023-2030 年调查期间的复合年增长率预计将达到 17.82%。

心臟生物标誌物是因心臟损伤或压力而释放到血液中的蛋白质分子。 这些生物标誌物可用于检测心血管疾病 (ACS)，例如心肌缺血、心肌梗塞、充血性心力衰竭和急性冠脉综合征。 心臟生物标誌物测试使医生能够评估患者出现这种情况的可能性。 肌钙蛋白、肌酸激□肌肉/脑 (CK-MB)、B 型钠尿□ (BNP)、高敏 C 反应蛋白 (hs-CRP)、肌钙蛋白 I 和 T、肌红蛋白、缺血修饰白蛋白 (IMA)、其他心臟生物标誌物通常被用作心血管疾病 (CVD) 的综合诊断方法。

市场动态：

随着老年人口的增长以及因生活方式改变而患心脏病和胸部不适的患者数量的增加，预计该市场将得到提振。 心血管和生活方式疾病患病率的增加、对特定疾病治疗的需求增加以及使用心臟生物标誌物的研究是推动市场增长的关键因素。 此外，心臟生物标誌物的技术进步和政府为提高人们对心血管疾病的认识而采取的积极举措是推动心臟生物标誌物市场发展的主要因素。 此外，公共和私人机构增加对心臟生物标誌物研究的资助也有望在未来几年推动市场增长。 然而，公众意识低下预计会阻碍行业扩张。

这份研究报告描述了波特的五力模型、市场吸引力分析和价值链分析。 这些工具可帮助您清楚地了解您的行业结构并评估您在全球范围内的竞争吸引力。 此外，这些工具还对全球心臟生物标誌物市场的每个细分市场进行了全面评估。 心臟生物标誌物行业的发展和趋势为这项研究提供了一种整体方法。

市场细分：

本部分按国家和地区提供详细的细分数据，以帮助您确定目标受众以及您的产品和服务的未来商机。

按类型

  • 心肌肌酸激□ (Ck-Mb)
  • 肌钙蛋白（T 和 i）
  • 肌红蛋白
  • 脑利钠□ (Bnps) 或 Nt-Probnp
  • 缺血修饰白蛋白 (Ima)
  • 其他

按申请

  • 心肌梗塞
  • 充血性心力衰竭
  • 急性冠状动脉综合征
  • 动脉粥样硬化
  • 其他

按测试地点

  • 护理点测试
  • 实验室测试

按地区分析：

本部分提供了北美、欧洲、亚太地区、拉丁美洲、中东和非洲心臟生物标誌物市场当前和未来需求的区域展望。 此外，它还侧重于所有主要地区每个单独应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的综合概况和全球竞争格局的详细视图。 心臟生物标誌物市场的主要参与者是罗氏诊断、雅培实验室、西门子医疗、Alere Inc.、Becton、Dickinson and Company、Bio-Rad Laboratories、BioMerieux、Randox laboratories、Beckman Coulter 和 Thermo Fisher Scientific。 本节全面介绍了竞争格局，包括各种战略发展，例如主要併购、未来能力、合作伙伴关係、财务概览、合作、新产品开发和新产品发布。

如果您有任何定制要求，请写信给我们。 我们的研究团队可以根据您的需要提供定制报告。

内容

第一章前言

  • 报告内容
    • 目的
    • 目标受众
    • USP（独特的销售建议）及其提供的内容
  • 调查范围
  • 调查方法
    • 市场调研流程
    • 市场研究方法

第 2 章执行摘要

  • 市场亮点
  • 全球市场概况

第 3 章心臟生物标誌物 - 行业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场製约因素
  • 机会
  • 行业趋势
  • 波特的五力分析
  • 市场吸引力分析
    • 按类型
    • 通过使用
    • 按测试位置
    • 按地区

第四章价值链分析

  • 价值链分析
  • 原材料分析
    • 原材料清单
    • 原材料製造商列表
    • 主要原材料价格走势
  • 潜在买家名单
  • 营销渠道
    • 直接营销
    • 间接营销
    • 市场发展趋势

第 5 章 COVID-19 爆发的影响分析

第 6 章心臟生物标誌物的全球市场分析：按类型

  • 按类型概述
  • 过去和未来的数据
  • 按类型分析
  • 心肌肌酸激□ (CK-MB) 市场：按地区
  • 肌钙蛋白（T 和 I）市场：按地区
  • 肌红蛋白市场：区域细分
  • 脑利钠□ (BNP) 或 NT-proBNP 市场：按地区
  • 缺血修饰白蛋白 (IMA) 市场：按地区
  • 其他市场：按地区

第 7 章心臟生物标誌物的全球市场分析：按应用

  • 总结：按应用
  • 过去和未来的数据
  • 分析：按应用
  • 心肌梗塞市场：区域细分
  • 充血性心力衰竭市场：按地区
  • 急性冠状动脉综合征市场：按地区
  • 动脉粥样硬化市场：按地区
  • 其他市场：按地区

第 8 章心臟生物标誌物的全球市场分析：按测试位置

  • 按测试位置列出大纲
  • 过去和未来的数据
  • 按测试地点分析
  • 即时检验市场：按地区
  • 实验室检测市场：按地区

第 9 章心臟生物标誌物的全球市场分析：按地区

  • 区域展望
  • 介绍
  • 北美
    • 摘要、实际数据、预测数据
    • 按北美细分
    • 北美：按国家/地区列出
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 摘要、实际数据、预测数据
    • 欧洲（按细分市场）
    • 欧洲：按国家/地区分类
    • 英国
    • 法国
    • 德国
    • 意大利
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 摘要、实际数据、预测数据
    • 按亚太地区细分
    • 亚太地区：国家/地区信息
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳大利亚
    • 其他亚太地区
  • 拉丁美洲
    • 摘要、实际数据、预测数据
    • 拉丁美洲细分市场
    • 拉丁美洲：按国家/地区列出
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲地区
  • 中东和非洲
    • 摘要、实际数据、预测数据
    • 中东和非洲分部信息
    • 中东和非洲：按国家/地区列出
    • 沙特阿拉伯
    • 阿联酋
    • 以色列
    • 南非
    • 其他中东和非洲地区

第10章心臟生物标誌物公司的竞争格局

  • 心臟生物标誌物市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他扩展

第11章公司简介

  • 公司股票分析
  • 市场集中度
  • 罗氏诊断
    • 公司简介
    • 产品介绍
    • 近期趋势
  • 雅培实验室
    • 公司简介
    • 产品介绍
    • 近期趋势
  • 西门子医疗
    • 公司简介
    • 产品介绍
    • 近期趋势
  • Alere 公司
    • 公司简介
    • 产品介绍
    • 近期趋势
  • 贝顿
    • 公司简介
    • 产品介绍
    • 近期趋势
  • 狄金森公司
    • 公司简介
    • 产品介绍
    • 近期趋势
  • Bio-Rad 实验室
    • 公司简介
    • 产品介绍
    • 近期趋势
  • 生物梅里埃
    • 公司简介
    • 产品介绍
    • 近期趋势
  • 朗道实验室
    • 公司简介
    • 产品介绍
    • 近期趋势
  • 贝克曼库尔特
    • 公司简介
    • 产品介绍
    • 近期趋势
  • 赛默飞世尔科技
    • 公司简介
    • 产品介绍
    • 近期趋势

注意：在公司简介、财务细节、近期发展等方面，基于可用信息，私人控股公司可能不包括在内。

Product Code: VMR11217049

The global demand for Cardiac Biomarkers Market is presumed to reach the market size of nearly USD 67.58 BN by 2030 from USD 18.2 BN in 2022 with a CAGR of 17.82% under the study period 2023 - 2030.

Cardiac biomarkers are protein molecules released into the bloodstream due to cardiac injury or stress. These biomarkers could be used to detect cardiac ischemia, myocardial infarction, congestive heart failure, and acute coronary syndrome, among other cardiovascular illnesses (ACS). Cardiac biomarker testing enables doctors to assess a patient's likelihood of developing such conditions. Troponin, creatine kinase-muscle/brain (CK-MB), B-type natriuretic peptide (BNP), high-sensitivity C-reactive protein (hs-CRP), troponin I and T, myoglobin, ischemia modified albumin (IMA), and other cardiac biomarkers are commonly employed as an integrated diagnostic method for cardiovascular diseases (CVDs).

Market Dynamics:

The market will likely be fueled by an increase in the senior population and patients suffering from heart attacks and chest discomfort due to changing lifestyles. The increasing prevalence of cardiovascular diseases and lifestyle diseases, increase in demand for disease-specific treatment, and research in which cardiac biomarkers are used are significant elements boosting the market growth. In addition, technological advancements in cardiac biomarkers and favourable government initiatives to raise awareness about cardiovascular diseases are the key factors driving the cardiac biomarkers market. Moreover, increased funding for cardiac biomarker research from both public and private institutions is likely to support market growth in the coming years. However, a lack of public awareness is projected to stifle industry expansion

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of cardiac biomarkers. The growth and trends of cardiac biomarkers industry provide a holistic approach to this study.

Market Segmentation:

This section of the cardiac biomarkers market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Myocardial Muscle Creatine Kinase (Ck-Mb)
  • Troponins (T And I)
  • Myoglobin
  • Brain Natriuretic Peptide (Bnps) Or Nt-Probnp
  • Ischemia Modified Albumin (Ima)
  • Others

By Application

  • Myocardial Infarction
  • Congestive Heart Failure
  • Acute Coronary Syndrome
  • Atherosclerosis
  • Others

By Location of Testing

  • Point Of Care Testing
  • Laboratory Testing

Regional Analysis:

This section covers the regional outlook, which accentuates current and future demand for the Cardiac Biomarkers market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the cardiac biomarkers market include Roche Diagnostics, Abbott Laboratories, Siemens Healthcare, Alere Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, BioMerieux, Randox laboratories, Beckman Coulter and Thermo Fisher Scientific. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . CARDIAC BIOMARKERS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 By Type
    • 3.7.2 By Application
    • 3.7.3 By Location of Testing
    • 3.7.4 By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL CARDIAC BIOMARKERS MARKET ANALYSIS BY TYPE

  • 6.1 Overview by Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Type
  • 6.4 Myocardial muscle Creatine Kinase (CK-MB) Market by Regions
  • 6.5 Troponins (T and I) Market by Regions
  • 6.6 Myoglobin Market by Regions
  • 6.7 Brain Natriuretic Peptide (BNPs) or NT-proBNP Market by Regions
  • 6.8 Ischemia Modified Albumin (IMA) Market by Regions
  • 6.9 Others Market by Regions

7 . GLOBAL CARDIAC BIOMARKERS MARKET ANALYSIS BY APPLICATION

  • 7.1 Overview by Application
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Application
  • 7.4 Myocardial Infarction Market by Regions
  • 7.5 Congestive Heart Failure Market by Regions
  • 7.6 Acute Coronary Syndrome Market by Regions
  • 7.7 Atherosclerosis Market by Regions
  • 7.8 Others Market by Regions

8 . GLOBAL CARDIAC BIOMARKERS MARKET ANALYSIS BY LOCATION OF TESTING

  • 8.1 Overview by Location of Testing
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Location of Testing
  • 8.4 Point of care Testing Market by Regions
  • 8.5 Laboratory Testing Market by Regions

9 . GLOBAL CARDIAC BIOMARKERS MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America
    • 9.3.1. Overview, Historic and Forecast Data
    • 9.3.2. North America By Segment
    • 9.3.3. North America By Country
    • 9.3.4. United State
    • 9.3.5. Canada
    • 9.3.6. Mexico
  • 9.4. Europe
    • 9.4.1. Overview, Historic and Forecast Data
    • 9.4.2. Europe by Segment
    • 9.4.3. Europe by Country
    • 9.4.4. United Kingdom
    • 9.4.5. France
    • 9.4.6. Germany
    • 9.4.7. Italy
    • 9.4.8. Russia
    • 9.4.9. Rest Of Europe
  • 9.5. Asia Pacific
    • 9.5.1. Overview, Historic and Forecast Data
    • 9.5.2. Asia Pacific by Segment
    • 9.5.3. Asia Pacific by Country
    • 9.5.4. China
    • 9.5.5. India
    • 9.5.6. Japan
    • 9.5.7. South Korea
    • 9.5.8. Australia
    • 9.5.9. Rest Of Asia Pacific
  • 9.6. Latin America
    • 9.6.1. Overview, Historic and Forecast Data
    • 9.6.2. Latin America by Segment
    • 9.6.3. Latin America by Country
    • 9.6.4. Brazil
    • 9.6.5. Argentina
    • 9.6.6. Peru
    • 9.6.7. Chile
    • 9.6.8. Rest of Latin America
  • 9.7. Middle East & Africa
    • 9.7.1. Overview, Historic and Forecast Data
    • 9.7.2. Middle East & Africa by Segment
    • 9.7.3. Middle East & Africa by Country
    • 9.7.4. Saudi Arabia
    • 9.7.5. UAE
    • 9.7.6. Israel
    • 9.7.7. South Africa
    • 9.7.8. Rest Of Middle East And Africa

10 . COMPETITIVE LANDSCAPE OF THE CARDIAC BIOMARKERS COMPANIES

  • 10.1. Cardiac Biomarkers Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF CARDIAC BIOMARKERS INDUSTRY

  • 11.1. Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Roche Diagnostics
    • 11.3.1. Company Overview
    • 11.3.2. Financials
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. Abbott Laboratories
    • 11.4.1. Company Overview
    • 11.4.2. Financials
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. Siemens Healthcare
    • 11.5.1. Company Overview
    • 11.5.2. Financials
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. Alere Inc.
    • 11.6.1. Company Overview
    • 11.6.2. Financials
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. Becton
    • 11.7.1. Company Overview
    • 11.7.2. Financials
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. Dickinson and Company
    • 11.8.1. Company Overview
    • 11.8.2. Financials
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. Bio-Rad Laboratories
    • 11.9.1. Company Overview
    • 11.9.2. Financials
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. BioMerieux
    • 11.10.1. Company Overview
    • 11.10.2. Financials
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. Randox laboratories
    • 11.11.1. Company Overview
    • 11.11.2. Financials
    • 11.11.3. Products
    • 11.11.4. Recent Developments
  • 11.12. Beckman Coulter
    • 11.12.1. Company Overview
    • 11.12.2. Financials
    • 11.12.3. Products
    • 11.12.4. Recent Developments
  • 11.13. Thermo Fisher Scientific
    • 11.13.1. Company Overview
    • 11.13.2. Financials
    • 11.13.3. Products
    • 11.13.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  • COVID-19: Micro and Macro Factor Analysis
  • Analysis by Type (USD MN)
  • Myocardial muscle Creatine Kinase (CK-MB) Market by Geography (USD MN)
  • Troponins (T and I) Market by Geography (USD MN)
  • Myoglobin Market by Geography (USD MN)
  • Brain Natriuretic Peptide (BNPs) or NT-proBNP Market by Geography (USD MN)
  • Ischemia Modified Albumin (IMA) Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Analysis Market by Application (USD MN)
  • Myocardial Infarction Market by Geography (USD MN)
  • Congestive Heart Failure Market by Geography (USD MN)
  • Acute Coronary Syndrome Market by Geography (USD MN)
  • Atherosclerosis Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Analysis by Location of Testing (USD MN)
  • Point of care Testing Market by Geography (USD MN)
  • Laboratory Testing Market by Geography (USD MN)
  • Global Cardiac Biomarkers Market by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton

LIST OF FIGURES

  • Research Scope of Cardiac Biomarkers Report
  • Market Research Process
  • Market Research Methodology
  • Global Cardiac Biomarkers Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Location of Testing
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Type (USD MN)
  • Myocardial muscle Creatine Kinase (CK-MB) Market by Geography (USD MN)
  • Troponins (T and I) Market by Geography (USD MN)
  • Myoglobin Market by Geography (USD MN)
  • Brain Natriuretic Peptide (BNPs) or NT-proBNP Market by Geography (USD MN)
  • Ischemia Modified Albumin (IMA) Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Myocardial Infarction Market by Geography (USD MN)
  • Congestive Heart Failure Market by Geography (USD MN)
  • Acute Coronary Syndrome Market by Geography (USD MN)
  • Atherosclerosis Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Market Analysis by Location of Testing (USD MN)
  • Point of care Testing Market by Geography (USD MN)
  • Laboratory Testing Market by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.